| 摘要: |
| 阿片类药物是治疗中晚期癌症疼痛的基础药物,阿片类药物在体内代谢主要依靠药物代谢酶,基因多态性是造成药物代谢酶多态性的主要遗传因素。近年来,阿片类药物和药物代谢酶基因多态性相关性被广泛研究,阿片类药物在体内代谢、运转效率和药物代谢酶基因多态性密切相关,等位基因上核苷酸序列的变化可能会导致显著的个体差异。因此,基于基因组学系统性总结和深入研究阿片类药物与药物代谢酶基因多态性相关性将有助于临床工作者精准医疗。 |
| 关键词: 阿片类药物 基因多态性 药物代谢酶 |
| DOI:10.13506/j.cnki.jpr.2024.11.012 |
| 基金项目:河北省自然科学基金项目(No.H2021405002) |
|
出版日期:2024-11-25
|
|
| Research progress of opioid drugs and gene polymorphism of drug metabolism enzymes |
| WANG Zeyu1,YAN Juan2 |
| (1.Hebei Key Laboratory of Neuropharmacology, Department of Pharmacy, Hebei North University, Zhangjiakou 075000,China;2 Department of Pharmacy,First Affiliated Hospital of Hebei North University,Zhangjiakou 075000,China) |
| Abstract: |
| Opioids serve as essential medications for managing advanced cancer pain. The in vivo metabolism of opioids primarily relies on drug-metabolizing enzymes, with genetic polymorphism being the primary determinant of enzyme variability in drug metabolism. The correlation between opioids and gene polymorphisms of drug metabolism enzymes has been extensively investigated in recent years. Opioid metabolism in vivo, transport efficiency, and gene polymorphisms of drug metabolism enzymes are intricately interconnected, with allelic nucleotide sequence variations potentially leading to significant interindividual differences. Therefore, a comprehensive and in-depth investigation into the correlation between opioids and genetic polymorphisms of drug metabolism enzymes based on genomics will facilitate clinicians in achieving precision medicine. |
| Key words: Opioids Genetic polymorphism Drug metabolic enzyme |